USPTO Affirms Gevo's Request for Reexamination of Butamax Patent
Gevo, Inc. (NASDAQ: GEVO) announced today that the U.S. Patent Office and Trademark (USPTO) has denied a petition by ButamaxTM Advanced Biofuels, LLC (Butamax) which would have vacated the order granting Gevo's reexamination request of Butamax's U.S. Patent No. 7,851,188.
In so doing, the USPTO simultaneously affirmed its original decision that all claims challenged by Gevo in the '188 patent remain rejected as unpatentable.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.